Cargando…
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine
The purpose of this article is to provide a focused overview of the current use of positron emission tomography (PET) molecular imaging in the burgeoning era of personalized medicine in the treatment of patients with glioma. Specifically, we demonstrate the utility of PET imaging as a tool for perso...
Autores principales: | Barajas, Ramon F., Krohn, Kenneth A., Link, Jeanne M., Hawkins, Randall A., Clarke, Jennifer L., Pampaloni, Miguel H., Cha, Soonmee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344267/ https://www.ncbi.nlm.nih.gov/pubmed/28536391 http://dx.doi.org/10.3390/biomedicines4040024 |
Ejemplares similares
-
Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma
por: Barajas, Ramon F., et al.
Publicado: (2015) -
Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013) -
Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas
por: Carrete, Luis R., et al.
Publicado: (2022) -
Modern Brain Tumor Imaging
por: Mabray, Marc C., et al.
Publicado: (2015) -
LOSS OF BIODIVERSITY: THE BURGEONING THREAT TO HUMAN HEALTH
por: Adebayo, Oladimeji
Publicado: (2019)